Nephros Inc
NASDAQ:NEPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nephros Inc
NASDAQ:NEPH
|
US |
|
Eloxx Pharmaceuticals Inc
F:3970
|
US |
|
Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
|
US |
Shareholder Yield
Current shareholder yield for NEPH is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Price Appreciation
NEPH Price
Nephros Inc
| Average Annual Return | 15.44% |
| Standard Deviation of Annual Returns | 132.66% |
| Max Drawdown | -91% |
| Market Capitalization | 30.1m USD |
| Shares Outstanding | 10 630 000 |
| Percentage of Shares Shorted | 0.05% |
NEPH Return Decomposition
Main factors of price return
Stock Splits
NEPH's latest stock split occurred on Jul 10, 2019
The company executed a 1-for-9 stock split, meaning that for every 9 shares held, investors received 1 new share.
Before the split, NEPH traded at 0.62 per share. Afterward, the share price was about 5.
The adjusted shares began trading on Jul 10, 2019. This was NEPH's 2nd stock split, following the previous one in Mar 17, 2011.
